MODI'IN, Israel (AP) _ Vascular Biogenics Ltd. (VBLT) on Tuesday reported a loss of $5.4 million in its third quarter.
On a per-share basis, the Modi'In, Israel-based company said it had a loss of 15 cents.
The gene therapy biotech company posted revenue of $101,000 in the period.
The company's shares closed at $1.12. A year ago, they were trading at $6.85.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VBLT at https://www.zacks.com/ap/VBLT